Trial intelligence / Profile preview

AEG33773 in painful diabetic peripheral neuropathy

NCT00891683Phase 2Completed

Sponsor
Aegera Therapeutics
Start
Mar 2009
Primary completion
Dec 2009
Countries
4
01

Overview

A Phase 2 trial of AEG33773 in diabetic peripheral neuropathy (DPN), sponsored by Aegera Therapeutics. Started Mar 2009; status: completed.

02

Drugs

AEG33773
03

Conditions

diabetic peripheral neuropathy (DPN)

Beyond the preview

Go deeper on NCT00891683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00891683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call